Not Yet Recruiting
Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
NCT07673367
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States